[HTML][HTML] Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease

SB Ong, SB Kalkhoran, HA Cabrera-Fuentes… - European journal of …, 2015 - Elsevier
The past decade has witnessed a number of exciting developments in the field of
mitochondrial dynamics–a phenomenon in which changes in mitochondrial shape and …

Critical role for stromal interaction molecule 1 in cardiac hypertrophy

JS Hulot, J Fauconnier, D Ramanujam, A Chaanine… - Circulation, 2011 - Am Heart Assoc
Background—Cardiomyocytes use Ca2+ not only in excitation-contraction coupling but also
as a signaling molecule promoting, for example, cardiac hypertrophy. It is largely unclear …

Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program

D Frank, C Kuhn, B Brors, C Hanselmann… - …, 2008 - Am Heart Assoc
Biomechanical stress ie, attributable to pressure overload, leads to cardiac hypertrophy and
may ultimately cause heart failure. Yet, it is still unclear how mechanical stress is sensed …

Sodium butyrate attenuates angiotensin II‐induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6‐dependent mechanism

L Zhang, M Deng, A Lu, Y Chen, Y Chen… - Journal of Cellular …, 2019 - Wiley Online Library
Sodium butyrate (NaBu) is reported to play important roles in a number of chronic diseases.
The present work is aimed to investigate the effect of NaBu on angiotensin II (Ang II) …

Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2

A Zoccarato, NC Surdo, JM Aronsen, LA Fields… - Circulation …, 2015 - Am Heart Assoc
Rationale: Chronic elevation of 3′-5′-cyclic adenosine monophosphate (cAMP) levels
has been associated with cardiac remodeling and cardiac hypertrophy. However …

Cardiovascular effects of leptin

G Sweeney - Nature Reviews Cardiology, 2010 - nature.com
A wealth of investigations, ranging from clinical and animal model studies to in vitro
analyses, have generated great interest in the cardiovascular effects of leptin. Accordingly …

The Hippo signaling pathway in cardiac development and diseases

MM Mia, MK Singh - Frontiers in cell and developmental biology, 2019 - frontiersin.org
Heart disease continues to be the leading cause of morbidity and mortality worldwide.
Cardiac malformation during development could lead to embryonic or postnatal death …

Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis

YM Zhang, J Bo, GE Taffet, J Chang, J Shi… - The FASEB …, 2006 - Wiley Online Library
Ventricular myocyte hypertrophy is an important compensatory growth response to pressure
overload. However, pathophysiological cardiac hypertrophy is accompanied by reactive …

Heart plasticity in response to pressure-and volume-overload: a review of findings in compensated and decompensated phenotypes

FG Pitoulis, CM Terracciano - Frontiers in Physiology, 2020 - frontiersin.org
The adult human heart has an exceptional ability to alter its phenotype to adapt to changes
in environmental demand. This response involves metabolic, mechanical, electrical, and …

Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease

Q Pang, L You, X Meng, Y Li, T Deng, D Li… - Biochemical …, 2023 - Elsevier
Individuals have known that Janus kinase (JAK) signal transducer and activator of
transcription (STAT) signaling pathway was involved in the growth of the cell, cell …